| 发明名称 |
7-[2-[4-(6-FLUORO-3-METHYL-1,2-BENZISOXAZOL-5-YL)-1-PIPERAZINYL]ETHYL]-2-(1-PROPYNYL)-7H-PYRAZOLO-[4,3-E]-[1,2,4]-TRIAZOLO-[1,5-C]-PYRIMIDIN-5 AMINE |
| 摘要 |
<p num="1"><br/><br/><br/>The compound having the structural formula I, or a pharmaceutically acceptable <br/>salt thereof, is disclosed, as well as its use in the treatment of central <br/>nervous system diseases, in particular Parkinson''s disease, Extra Pyramidal <br/>Syndrome, restless legs syndrome and attention deficit hyperactivity disorder, <br/>pharmaceutical compositions comprising it, and combinations with other agents.<br/>
|
| 申请公布号 |
CA2623047(C) |
申请公布日期 |
2013.04.23 |
| 申请号 |
CA20062623047 |
申请日期 |
2006.09.21 |
| 申请人 |
SCHERING CORPORATION |
发明人 |
BOYLE, CRAIG D.;CHACKALAMANNIL, SAMUEL;SHAH, UNMESH G.;LACHOWICZ, JEAN E. |
| 分类号 |
C07D487/14;A61K31/519;A61P25/14;A61P25/16 |
主分类号 |
C07D487/14 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
